A detailed history of Western Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Western Wealth Management, LLC holds 8,569 shares of LLY stock, worth $7.74 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
8,569
Previous 8,717 1.7%
Holding current value
$7.74 Million
Previous $6.78 Million 14.41%
% of portfolio
0.58%
Previous 0.53%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $107,280 - $134,537
-148 Reduced 1.7%
8,569 $7.76 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $1.02 Million - $1.37 Million
-1,727 Reduced 16.54%
8,717 $6.78 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $582,960 - $687,234
1,110 Added 11.89%
10,444 $6.09 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $185,616 - $255,901
427 Added 4.79%
9,334 $5.01 Million
Q2 2023

Aug 30, 2023

BUY
$350.74 - $468.98 $179,578 - $240,117
512 Added 6.1%
8,907 $4.18 Million
Q1 2023

Aug 30, 2023

BUY
$310.63 - $364.82 $383,628 - $450,552
1,235 Added 17.25%
8,395 $2.88 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $1.61 Million - $1.87 Million
-4,999 Reduced 41.11%
7,160 $2.62 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $683,089 - $778,452
2,304 Added 23.38%
12,159 $4 Million
Q2 2022

Jul 18, 2022

SELL
$278.73 - $327.27 $119,296 - $140,071
-428 Reduced 4.16%
9,855 $3.21 Million
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $1.38 Million - $1.72 Million
5,881 Added 133.6%
10,283 $2.95 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $405,404 - $503,109
-1,803 Reduced 29.06%
4,402 $1.22 Million
Q2 2021

Aug 09, 2021

BUY
$180.55 - $233.54 $383,307 - $495,805
2,123 Added 52.01%
6,205 $1.42 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $34,671 - $44,883
211 Added 5.45%
4,082 $763,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $138,287 - $182,987
-1,060 Reduced 21.5%
3,871 $654,000
Q3 2020

Oct 27, 2020

SELL
$146.22 - $169.13 $18,131 - $20,972
-124 Reduced 2.45%
4,931 $730,000
Q2 2020

Jul 20, 2020

BUY
$136.42 - $164.18 $10,913 - $13,134
80 Added 1.61%
5,055 $830,000
Q1 2020

Apr 27, 2020

BUY
$119.05 - $147.35 $15,238 - $18,860
128 Added 2.64%
4,975 $687,000
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $56,453 - $69,923
-528 Reduced 9.82%
4,847 $637,000
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $103,693 - $112,791
971 Added 22.05%
5,375 $599,000
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $95,722 - $111,732
-864 Reduced 16.4%
4,404 $486,000
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $11,353 - $13,364
-102 Reduced 1.9%
5,268 $684,000
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $568,683 - $637,096
5,370 New
5,370 $622,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.